Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Esophageal Neoplasms 2Anastomotic Leak 2Vascular Malformations 1Neoplasms 1

Interventions

Sirolimus 2mirdametinib 1Vincristine 1Timolol 1Tablets 1Sildenafil Citrate 1Ointments 1Mupirocin 1Lasers, Dye 1Everolimus 1Blood Specimen Collection 1Bioseal 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vascular Malformations × Bioseal × Clear all
NCT03110783 2019-11-18

Bioseal Dural Sealing Study BIOS-14-001

Guangzhou Bioseal Biotechnology Co., Ltd.

Phase 3 Completed
200 enrolled

Neoplasms, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡